Latest Breaking News On - Immunic inc - Page 1 : comparemela.com

Immunic Inc. CEO Daniel Vitt Highlights Advances in MS Treatment on World MS Day

Immunic Inc. CEO Daniel Vitt Highlights Advances in MS Treatment on World MS Day
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Daniel-vitt
Immunic-inc
Steve-darling

Immunic to Participate in Industry and Scientific Conferences in June

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.

San-diego
California
United-states
Ukraine
Russia
Netherlands
Den-haag
Zuid-holland
Werner-gladdines
Edna-kaplan
Jessica-breu
Paula-schwartz

EQS-News: Immunic AG: Immunic to Participate in Industry and Scientific Conferences in June

Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Industry and Scientific Conferences in June 28.05.2024 / 12:30 CET/CEST The issuer is solely responsible

Netherlands
Den-haag
Zuid-holland
California
United-states
Russia
San-diego
Ukraine
Jessica-breu
Edna-kaplan
Werner-gladdines
Paula-schwartz

Immunic sets out June conference appearances

Immunic Inc (NASDAQ:IMUX) will be present at two conferences in June. At the BIO International Convention in San Diego, Jessica Breu, VP of Investor.

Netherlands
San-diego
California
United-states
Den-haag
Zuid-holland
Werner-gladdines
Jessica-breu
Contract-management-group-assembly-on
Program-management-clinical-development-operations
Immunic-inc
International-convention

Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day

Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Andreas-muehler
Immunic-inc
Clinical-trials-day